Martingale Asset Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,034
Closed -$128K 942
2020
Q4
$128K Sell
14,034
-67,561
-83% -$523K ﹤0.01% 861
2020
Q3
$497K Sell
81,595
-5,799
-7% -$44.3K 0.01% 815
2020
Q2
$777K Buy
87,394
+48,147
+123% +$415K 0.01% 793
2020
Q1
$285K Buy
+39,247
New +$291K ﹤0.01% 888

Other funds holding NPTN

Martingale Asset Management's NPTN Position: Q1 2021 in Review

Martingale Asset Management sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 14,034 shares — an estimated $128K sold.

Martingale Asset Management first reported a position in NPTN in Q1 2020 and held it in 4 quarters. The position peaked at $777K in Q2 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Martingale Asset Management reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Martingale Asset Management sold 14,034 NEOPHOTONICS CORP shares in Q1 2021, an estimated $128K.
  • Martingale Asset Management first reported a position in NEOPHOTONICS CORP in Q1 2020 and held it in 4 quarters.
  • Martingale Asset Management's NEOPHOTONICS CORP position peaked at $777K in Q2 2020.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Martingale Asset Management's 13F filing for Q1 2021, filed 13 May 2021.